Filter
598
Text search:
molecular
Featured
Recommendations
66
New Publications
98
Language
Document type
No document type
255
Guidelines
126
Studies & Reports
112
Manuals
39
Strategic & Response Plan
25
Fact sheets
24
Training Material
8
Situation Updates
4
Resource Platforms
2
Infographics
2
Videos
1
Countries / Regions
India
30
Brazil
24
Western and Central Europe
24
Global
24
Latin America and the Carribbean
20
Eastern Europe
16
Africa
10
Tanzania
9
Kenya
8
Colombia
8
Uganda
7
Malawi
7
West and Central Africa
7
Congo, Democratic Republic of
6
Rwanda
6
South–East Asia Region
6
Paraguay
6
Ethiopia
5
Philippines
5
South Africa
5
Venezuela
5
Russia
5
Nigeria
4
Germany
4
Syria
4
Ukraine
4
Ecuador
4
Senegal
3
Zimbabwe
3
Argentina
3
El Salvador
3
East and Southern Africa
3
Asia
3
Sierra Leone
2
Liberia
2
USA
2
Haiti
2
Pakistan
2
South Sudan
2
Zambia
2
Bangladesh
2
Namibia
2
Peru
2
Bolivia
2
Myanmar / Burma
2
Western Pacific Region
2
Tajikistan
2
Vietnam
2
France
2
Spain
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Somalia
1
Nepal
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Chad
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Malaysia
1
Mozambique
1
Benin
1
Eswatini/ Swaziland
1
North Macedonia
1
Botswana
1
Angola
1
Guatemala
1
Mexico
1
Chile
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Kazakhstan
1
Turkmenistan
1
Japan
1
United Kingdom
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
178
Clinical Guidelines
74
Public Health
29
Pharmacy & Technologies
28
Key Resources
14
Women & Child Health
11
Capacity Building
3
Toolboxes
TB
133
COVID-19
83
NTDs
50
AMR
34
HIV
30
Mental Health
29
Planetary Health
18
Rapid Response
13
Ebola & Marburg
12
NCDs
10
Refugee
9
Zika
9
Specific Hazards
8
Malaria
8
Polio
6
Pharmacy
6
Cholera
5
2.0 Rapid Response
5
Disability
4
Caregiver
4
Conflict
3
Natural Hazards
3
Global Health Education
2
Health Financing Toolbox
1
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo
...
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
17–24 November 2015
The purpose of this document is to present concise information on the current case definitions for dengue, chikungunya, and Zika proposed by PAHO, as well as information on the clinical phases and severity classification of dengue and chikungunya.
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
This guidance covers diagnosis and care of patients with long-term effects of COVID-19. It makes recommendations for the care of adults and children who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It is meant for health and care practitioners. This interim documen
...
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required to offer significant health benefits and mitigate he
...
Ciudad de México, México - 26 al 28 de mayo del 2014
Elaborat în cadrul proiectului „Fortificarea controlului tuberculozei în Moldova”, finanţat de către
Fondul Global de combatere a SIDA, Tuberculozei şi Malariei.
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani
...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio
...
